New biocomposite aims to mend broken bones better than standard care

NCT ID NCT07209033

Recruiting now Disease control Sponsor: Medical Inventi S.A. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new bone-regeneration material called FlexiOss® to the usual treatment for people with broken bones from accidents. About 80 adults aged 18-75 with fresh bone defects in the leg or foot will receive either FlexiOss® or standard care. Researchers will check bone healing, safety, and quality of life over 2 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE DEFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease of bone structure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE DEFECT

Contacts and locations

Locations

Klinika Chirurgii Urazowej Narządu Ruchu i Ortopedii CMKP Samodzielny Publiczny Szpital Kliniczny im. prof. Adama Grucy Centrum Medycznego Kształcenia Podyplomowego
RECRUITING

Otwock, 05-400, Poland
Klinika Chirurgii Urazowej i Ortopedii 5 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ
RECRUITING

Krakow, 30-901, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.